| 1.92 0.1 (5.49%) | 06-30 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.5 | 1-year : | 2.88 |
| Resists | First : | 2.14 | Second : | 2.47 |
| Pivot price | 1.79 |
|||
| Supports | First : | 1.62 | Second : | 1.34 |
| MAs | MA(5) : | 1.81 |
MA(20) : | 1.8  |
| MA(100) : | 2.32 |
MA(250) : | 2.65 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 36.3 |
D(3) : | 42.7 |
| RSI | RSI(14): 51.1 |
|||
| 52-week | High : | 4.09 | Low : | 1.57 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ PETS ] has closed It is unclear right now based on current values. 46.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 2.47 - 2.49 | 2.49 - 2.5 |
| Low: | 1.73 - 1.75 | 1.75 - 1.76 |
| Close: | 1.8 - 1.82 | 1.82 - 1.84 |
PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines. Their non-prescription offerings include products for flea and tick prevention, joint and bone care, vitamins, treats, nutritional supplements, hygiene essentials, and general pet supplies. For prescription needs, they supply heartworm and flea/tick preventatives, alongside medications for conditions such as arthritis, dermatitis, thyroid imbalances, diabetes, pain relief, and cardiovascular issues, often providing generic alternatives. Beyond pharmaceuticals, the company also retails pet food, bedding, crates, stairs, and various other accessories. PetMed Express engages with its clientele through multiple distribution channels: its official website, a dedicated mobile application, a telephone contact center, direct mail campaigns (like brochures and postcards), and television advertisements, frequently promoting its 1-800-PetMeds and PetMeds brands. The company was established in 1996 and is headquartered in Delray Beach, Florida.
Tue, 30 Jun 2026
PETS Stock Jumps As SilverCape Targets Takeover Amid Strain - StocksToTrade
Tue, 30 Jun 2026
PetMed Express receives $3 per share acquisition proposal - grafa.com
Tue, 30 Jun 2026
PetMed Express (PETS) Receives Acquisition Proposal from SilverC - GuruFocus
Tue, 30 Jun 2026
PetMed Express board weighs a $3-a-share buyout bid - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Pharmaceuticals
|
|
| Shares Out | 21 (M) |
| Shares Float | 14 (M) |
| Held by Insiders | 16.2 (%) |
| Held by Institutions | 44.7 (%) |
| Shares Short | 612 (K) |
| Shares Short P.Month | 579 (K) |
| EPS | -2.75 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 1.52 |
| Profit Margin | -32 % |
| Operating Margin | -9.4 % |
| Return on Assets (ttm) | -15.5 % |
| Return on Equity (ttm) | -100.5 % |
| Qtrly Rev. Growth | -15.7 % |
| Gross Profit (p.s.) | 2.35 |
| Sales Per Share | 8.37 |
| EBITDA (p.s.) | -0.89 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -28 (M) |
| Levered Free Cash Flow | -20 (M) |
| PE Ratio | -0.71 |
| PEG Ratio | 2.3 |
| Price to Book value | 1.25 |
| Price to Sales | 0.22 |
| Price to Cash Flow | -1.45 |
| Dividend | 0.3 |
| Forward Dividend | 0 |
| Dividend Yield | 15.6% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|